Source: Neuro-Oncology. Conference titles: Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology. Unidade: FMRP
Subjects: EPIGÊNESE GENÉTICA, GLIOMA, NEOPLASIAS CEREBRAIS, METILAÇÃO DE DNA, RADIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TESILEANU, C. Mircea S. et al. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/neuonc/noaa215.693. Acesso em: 09 nov. 2024. , 2020APA
Tesileanu, C. M. S., Van den Bent, M., Sabedot, T., Sanson, M., Brandes, A., Wick, W., et al. (2020). Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon. Neuro-Oncology. Cary: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1093/neuonc/noaa215.693NLM
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693Vancouver
Tesileanu CMS, Van den Bent M, Sabedot T, Sanson M, Brandes A, Wick W, Clement P, Erridge S, Vogelbaum M, Nowak A, Baurain J, Mason W, Wheeler H, Weller M, Heer I de, Dubbink H, Kros JM, Aldape K, Wesseling P, Golfinopoulos V, Gorlia T, Baumert B, Noushmehr H, French P. Prognostic significance of epigenetic subtypes and CPGS associated with progression to G-CIMP low in the eortc randomized phase III intergroup catnon [Internet]. Neuro-Oncology. 2020 ; 22( suppl. 2): ii166.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1093/neuonc/noaa215.693